ReleaseWire

Global Markets Direct's, 'WhanIn Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the WhanIn Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Ragweed Allergy Global Clinical Trials Review, H2, 2014" provides data on the Ragweed Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ragweed Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ragweed Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Chronic Plaque Psoriasis - Pipeline Review, H2 2014', provides an overview of the Chronic Plaque Psoriasis's therapeutic pipeline.

Global Markets Direct's, 'Ovarian Cancer - Pipeline Review, H2 2014', provides an overview of the Ovarian Cancer's therapeutic pipeline.

Global Markets Direct's, 'Liver Fibrosis - Pipeline Review, H2 2014', provides an overview of the Liver Fibrosis's therapeutic pipeline.

Global Markets Direct's, 'Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H2 2014', provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome)'s therapeutic pipeline.

Global Markets Direct's, 'CytImmune Sciences, Inc. - Product Pipeline Review - 2014', provides an overview of the CytImmune Sciences, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'AngioChem Inc. - Product Pipeline Review - 2014', provides an overview of the AngioChem Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Burns - Pipeline Review, H2 2014', provides an overview of the Burns's therapeutic pipeline.

Global Markets Direct's, 'Overactive Bladder - Pipeline Review, H2 2014', provides an overview of the Overactive Bladder's therapeutic pipeline.

GlobalData's clinical trial report, "Hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Hypersensitivity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypersensitivity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypersensitivity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Molecular Partners AG - Product Pipeline Review - 2014', provides an overview of the Molecular Partners AG's pharmaceutical research and development focus.

Global Markets Direct's, 'TaiMed Biologics Inc. - Product Pipeline Review - 2014', provides an overview of the TaiMed Biologics Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014', provides an overview of the Amyotrophic Lateral Sclerosis's therapeutic pipeline.

Global Markets Direct's, 'Medisyn Technologies, Inc. - Product Pipeline Review - 2014', provides an overview of the Medisyn Technologies, Inc.'s pharmaceutical research and development focus.

Orphan Drug Market Access: Payer Insights on the Present and Future is a report that examines the regulation, pricing, reimbursement, players and stakeholder/payer interests that are shaping the current and future direction of the orphan drug sector.

Global Markets Direct's, 'IkerChem S.L. - Product Pipeline Review - 2014', provides an overview of the IkerChem S.L.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Pharnext SAS - Product Pipeline Review - 2014', provides an overview of the Pharnext SAS's pharmaceutical research and development focus.

GlobalData's report "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells industry. It discusses key development trends, regulatory requirements in various markets, recent deals activity and industry dynamic trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as China, India, South Korea, and Israel-providing in-depth analysis of these markets' regulatory framework, key domestic players and their stem cell pipelines, and strategic outlook.

Global Markets Direct's, 'Non-Hodgkin Lymphoma - Pipeline Review, H2 2014', provides an overview of the Non-Hodgkin Lymphoma's therapeutic pipeline.

Global Markets Direct's, 'B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2014', provides an overview of the B-Cell Chronic Lymphocytic Leukemia's therapeutic pipeline.

Scott Steiger lives in St. Louis but has seen most of the world. As an engineer for the past 20 years, he’s traveled extensively and prior to that, Steiger was a member of the military service. He’s been to six of the seven continents. Travel is a big part of his life.

Global Markets Direct's, 'N30 Pharmaceuticals - Product Pipeline Review - 2014', provides an overview of the N30 Pharmaceuticals's pharmaceutical research and development focus.

Global Markets Direct's, 'Depression - Pipeline Review, H2 2014', provides an overview of the Depression's therapeutic pipeline.

Global Markets Direct's, 'Alzheimer's Disease - Pipeline Review, H2 2014', provides an overview of the Alzheimer's Disease's therapeutic pipeline.